Visibility and Traceability in the Biopharmaceutical Industry

1) Overview of biopharmaceutical supply chains
2) Historical perspective of functional challenges
3) Establishing internal End to End visibility and traceability
4) Visibility with partners and suppliers
5) The elephant in the room, collaboration with downstream distributors
6) Track and Trace serialization for anti-counterfeiting 
7) The potential to provide visibility from suppliers across manufacturing, distributors, and ultimately pharmacies

Facilitator: Allen Jacques

Allen is an Industry Thought Leader at Kinaxis. A veteran planning and operations leader, he has served as VP of Global Technical Operations & Biologics and External Manufacturing for Leo Pharma, VP of Network Supply Planning at Pfizer, VP of Pharma Supply Chain at FusionOps, as well as holding Director level roles at Baxter and Wyeth. He holds a BS in Microbiology from the University of Maryland and did graduate studies in Biochemistry at Johns Hopkins.

Certification of Maintenance: 2 points